Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples "Federico II", Naples, Italy; WAO Center of Excellence, Naples, Italy; Institute of Experimental Endocrinology and Oncology "G. Salvatore", National Research Council, Naples, Italy.
Translational Medical and Surgical Science, University of Campania "Luigi Vanvitelli", Naples, Italy.
Cytokine. 2021 Feb;138:155378. doi: 10.1016/j.cyto.2020.155378. Epub 2020 Nov 25.
In this study we investigated the effects of snake venom Group IA secreted phospholipase A (svGIA) on the release of inflammatory and angiogenic mediators from human lung macrophages (HLMs). HLMs were incubated with lipopolysaccharide (LPS) or svGIA with or without macrophage-polarizing stimuli (IL-4, IL-10, IFN-γ or the adenosine analogue NECA). M2-polarizing cytokines (IL-4 and IL-10) inhibited TNF-α, IL-6, IL-12, IL-1β, CXCL8 and CCL1 release induced by both LPS and svGIA. IL-4 inhibited also the release of IL-10. IFN-γ reduced IL-10 and IL-12 and increased CCL1 release by both the LPS and svGIA-stimulated HLMs, conversely IFN-γ reduced IL-1β only by svGIA-stimulated HLMs. In addition, IFNγ promoted TNF-α and IL-6 release from svGIA-stimulated HLMs to a greater extent than LPS. NECA inhibited TNF-α and IL-12 but promoted IL-10 release from LPS-stimulated HLMs according to the well-known effect of adenosine in down-regulating M1 activation. By contrast NECA reduced TNF-α, IL-10, CCL1 and IL-1β release from svGIA-activated HLM. IL-10 and NECA increased both LPS- and svGIA-induced vascular endothelial growth factor A (VEGF-A) release. By contrast, IL-10 reduced angiopoietin-1 (ANGPT1) production from activated HLMs. IFN-γ and IL-4 reduced VEGF-A and ANGPT1 release from both LPS- and svGIA-activated HLMs. Moreover, IL-10 inhibited LPS-induced ANGPT2 production. In conclusion, we demonstrated a fine-tuning modulation of svGIA-activated HLMs differentially exerted by the classical macrophage-polarizing cytokines.
在这项研究中,我们研究了蛇毒组 I A 分泌的磷脂酶 A(svGIA)对人肺巨噬细胞(HLMs)释放炎症和血管生成介质的影响。HLMs 与脂多糖(LPS)或 svGIA 孵育,同时存在或不存在巨噬细胞极化刺激物(IL-4、IL-10、IFN-γ 或腺苷类似物 NECA)。M2 极化细胞因子(IL-4 和 IL-10)抑制 LPS 和 svGIA 诱导的 TNF-α、IL-6、IL-12、IL-1β、CXCL8 和 CCL1 释放。IL-4 还抑制了 IL-10 的释放。IFN-γ 减少了 LPS 和 svGIA 刺激的 HLMs 释放的 IL-10 和 IL-12,并增加了 CCL1 的释放,相反 IFN-γ 仅通过 svGIA 刺激的 HLMs 减少了 IL-1β 的释放。此外,IFNγ 促进了 svGIA 刺激的 HLMs 中 TNF-α 和 IL-6 的释放,比 LPS 更为显著。NECA 抑制了 LPS 刺激的 HLMs 中 TNF-α 和 IL-12 的释放,但根据腺苷下调 M1 激活的已知作用,促进了 IL-10 的释放。相比之下,NECA 减少了 svGIA 激活的 HLMs 中 TNF-α、IL-10、CCL1 和 IL-1β 的释放。IL-10 和 NECA 增加了 LPS 和 svGIA 诱导的血管内皮生长因子 A(VEGF-A)的释放。相比之下,IL-10 减少了激活的 HLMs 中血管生成素-1(ANGPT1)的产生。IFN-γ 和 IL-4 减少了 LPS 和 svGIA 激活的 HLMs 中 VEGF-A 和 ANGPT1 的释放。此外,IL-10 抑制了 LPS 诱导的 ANGPT2 产生。总之,我们证明了经典的巨噬细胞极化细胞因子对 svGIA 激活的 HLMs 进行了精细的调节。